CoreCap Advisors’s Globus Medical GMED Stock Holding History

CoreCap Advisors’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$711	Sell	9 -16	-64%	-$1.36K	﹤0.01%	2771
2026 Q1	$2.15K	Hold	25	–	–	﹤0.01%	2395
2025 Q4	$2.18K	Buy	+25	New	+$1.9K	﹤0.01%	2457
2025 Q2	–	Sell	-3	Closed	-$220	–	2942
2025 Q1	$220	Buy	+3	New	+$248	﹤0.01%	2936
2022 Q4	$817	Buy	+11	New	+$749	﹤0.01%	2081
2022 Q3	–	Sell	-11	Closed	-$1K	–	1132
2022 Q2	$1K	Buy	+11	New	+$723	﹤0.01%	1988
2022 Q1	–	Sell	-11	Closed	-$1K	–	1140
2021 Q4	$1K	Buy	+11	New	+$799	﹤0.01%	2128

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

CoreCap Advisors's GMED Position: Q2 2026 in Review

CoreCap Advisors reduced its Globus Medical (GMED) stake by 64% in Q2 2026, selling an estimated $1.36K and leaving 9 shares worth $711. The position accounts for ﹤0.01% of the portfolio, ranked #2771.

CoreCap Advisors first reported a position in GMED in Q4 2021 and has held it in 7 quarters since. The position peaked at $2.18K in Q4 2025. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

CoreCap Advisors held 9 shares of Globus Medical worth $711 as of Q2 2026.
CoreCap Advisors sold 16 Globus Medical shares in Q2 2026, an estimated $1.36K.
Globus Medical made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #2771 holding.
CoreCap Advisors first reported a position in Globus Medical in Q4 2021 and has held it in 7 quarters since.
CoreCap Advisors's Globus Medical position peaked at $2.18K in Q4 2025.
599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.